135 related articles for article (PubMed ID: 38785479)
21. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
22. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
[TBL] [Abstract][Full Text] [Related]
23. Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer.
Haugen H; Johansson KA; Mercke C
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):109-19. PubMed ID: 11777628
[TBL] [Abstract][Full Text] [Related]
24. [Radiotherapy of carcinoma of the glottis in the initial stage].
Neri S; Belli A; Caliceti U; Emiliani E; Frezza G; Palazzi Trivelli A; Silvano M; Zini G; Babini L; Barbieri E
Radiol Med; 1987 Oct; 74(4):338-40. PubMed ID: 3671804
[TBL] [Abstract][Full Text] [Related]
25. The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.
Lyhne NM; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Evensen J; Mortensen HR; Overgaard J
Radiother Oncol; 2015 Oct; 117(1):91-8. PubMed ID: 26255764
[TBL] [Abstract][Full Text] [Related]
26. Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.
Ermiş E; Teo M; Dyker KE; Fosker C; Sen M; Prestwich RJ
Radiat Oncol; 2015 Sep; 10():203. PubMed ID: 26395876
[TBL] [Abstract][Full Text] [Related]
27. Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index.
Sakata K; Oouchi A; Nagakura H; Akiba H; Tamakawa M; Koito K; Hareyama M; Asakura K; Satoh M; Ohtani S
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):81-8. PubMed ID: 10758308
[TBL] [Abstract][Full Text] [Related]
28. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
[TBL] [Abstract][Full Text] [Related]
29. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
Wang CC; Nakfoor BM; Spiro IJ; Martins P
Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
[TBL] [Abstract][Full Text] [Related]
30. Salvage endoscopic angiolytic KTP laser treatment of early glottic cancer after failed radiotherapy.
Barbu AM; Burns JA; Lopez-Guerra G; Landau-Zemer T; Friedman AD; Zeitels SM
Ann Otol Rhinol Laryngol; 2013 Apr; 122(4):235-9. PubMed ID: 23697320
[TBL] [Abstract][Full Text] [Related]
31. Conventional fractionation should not be the standard of care for T2 glottic cancer.
Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ
Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654
[TBL] [Abstract][Full Text] [Related]
32. Treatment outcomes of the patients with early glottic cancer treated with initial radiotherapy and salvaged by conservative surgery.
Harada A; Sasaki R; Miyawaki D; Yoshida K; Nishimura H; Ejima Y; Kitajima K; Saito M; Otsuki N; Nibu K
Jpn J Clin Oncol; 2015 Mar; 45(3):248-55. PubMed ID: 25502310
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factor of telecobalt therapy for early glottic carcinoma.
Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
Cancer; 1992 Dec; 70(12):2797-801. PubMed ID: 1451057
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
35. Partial laryngectomy after irradiation failure.
Yiotakis J; Stavroulaki P; Nikolopoulos T; Manolopoulos L; Kandiloros D; Ferekidis E; Adamopoulos G
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):200-9. PubMed ID: 12601315
[TBL] [Abstract][Full Text] [Related]
36. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
[TBL] [Abstract][Full Text] [Related]
37. Transoral laser microsurgery for Tis, T1, and T2 glottic carcinoma: 5-year follow-up.
De Seta D; Campo F; D'Aguanno V; Ralli M; Greco A; Russo FY; de Vincentiis M
Lasers Med Sci; 2021 Apr; 36(3):507-512. PubMed ID: 32472425
[TBL] [Abstract][Full Text] [Related]
38. Study design and early result of a phase I study of SABR for early-stage glottic cancer.
Yu T; Wee CW; Choi N; Wu HG; Kang HC; Park JM; Kim JI; Kim JH; Kwon TK; Chung EJ
Laryngoscope; 2018 Nov; 128(11):2560-2565. PubMed ID: 29756264
[TBL] [Abstract][Full Text] [Related]
39. Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer.
Sher DJ; Timmerman RD; Nedzi L; Ding C; Pham NL; Zhao B; Sumer BD
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):110-118. PubMed ID: 30880269
[TBL] [Abstract][Full Text] [Related]
40. Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer.
Kang BH; Yu T; Kim JH; Park JM; Kim JI; Chung EJ; Kwon SK; Kim JH; Wu HG
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):104-109. PubMed ID: 30880271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
